• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why bluebird bio Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket

    7/19/23 8:11:59 AM ET
    $AMRN
    $AQMS
    $AUR
    $BLUE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Metal Fabrications
    Industrials
    Get the next $AMRN alert in real time by email

    Gainers

    • 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) shares surged 23.6% to $2.99 in pre-market trading after dipping 21% on Tuesday.
    • Deep Medicine Acquisition Corp. (NASDAQ:DMAQ) shares gained 25.4% to $14.42 in pre-market trading. Deep Medicine Acquisition And Bright Vision Sponsor LLC have made non-redemption agreements with six unaffiliated third parties, as per reports filed on July 12, 2023 and July 14, 2023.
    • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) rose 16.1% to $0.1695 in pre-market trading. Security Matters Has received a notice of allowance for its U.S. patent application 17/285,167 Titled "System And Method For Detection And Identification Of Foreign Elements In A Substance By X-Ray Or Gamma-Ray Detection And Emission."
    • Startek, Inc. (NYSE:SRT) shares rose 14.3% to $3.27 in pre-market trading. CSP Management Ltd said on July 18, CSP EAF II GP Limited, as general partner of CSP Fund II LP (CSP EAF) submitted an offer letter to Startek's board.
    • bluebird bio, Inc. (NASDAQ:BLUE) shares gained 14% to $3.59 in pre-market trading. B of A Securities upgraded bluebird bio from Neutral to Buy and raised the price target from $6 to $10.
    • Brenmiller Energy Ltd (NASDAQ:BNRG) shares rose 9.3% to $1.00 in pre-market trading.
    • Nxu, Inc. (NASDAQ:NXU) gained 7.6% to $0.6294 in pre-market trading.
    • Rubicon Technologies, Inc. (NASDAQ:RBT) rose 7.3% to $0.5840 in pre-market trading after jumping 39% on Tuesday.
    • DSS, Inc. (NYSE:DSS) gained 6.8% to $0.30 in pre-market trading. DSS recently appointed Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.
    • FOXO Technologies Inc. (NYSE:FOXO) shares climbed 6.6% to $0.1610 in pre-market trading.

    Losers

    • Sono Group N.V. (NASDAQ:SEV) fell 31.8% to $0.2278 in pre-market trading after the company received a notice of delisting from the Nasdaq.
    • Aqua Metals, Inc. (NASDAQ:AQMS) fell 23.7% to $1.29 in pre-market trading after the company reported a proposed public offering of common stock.
    • ViewRay, Inc. (NASDAQ:VRAY) fell 19.1% to $0.0715 in pre-market trading after jumping 29% on Tuesday. ViewRay recently filed voluntary Chapter 11 petitions.
    • Peraso Inc. (NASDAQ:PRSO) shares dropped 18.4% to $0.32 in pre-market trading after declining around 4% on Tuesday.
    • Bruush Oral Care Inc. (NASDAQ:BRSH) fell 18.1% to $0.1311 in pre-market trading after declining around 5% on Tuesday.
    • Dynatronics Corporation (NASDAQ:DYNT) shares fell 17.5% to $0.70 in pre-market trading.
    • ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) fell 16.3% to $0.1940 in pre-market trading after declining 8% on Tuesday.
    • Amarin Corporation plc (NASDAQ:AMRN) fell 16.1% to $1.20 in pre-market trading. Amarin named Patrick Holt as President and CEO. The company announced reorganization and reduction of 30% of non-sales roles.
    • Aurora Innovation, Inc. (NASDAQ:AUR) fell 14% to $2.77 in pre-market after the company disclosed plans to sell $600 million worth of stock in a private placement.
    • Biophytis S.A. (NASDAQ:BPTS) shares fell 11.6% to $2.75 in pre-market trading after reporting a $3.8 million registered direct offering.

     

    Now Read This: Market Volatility Declines Following Strong Bank Earnings; S&P 500 Settles Higher

    Get the next $AMRN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMRN
    $AQMS
    $AUR
    $BLUE

    CompanyDatePrice TargetRatingAnalyst
    Aptera Motors Corp.
    $SEV
    3/9/2026$10.00Buy
    Alliance Global Partners
    Aurora Innovation Inc.
    $AUR
    4/15/2025$10.00Buy
    Needham
    Aurora Innovation Inc.
    $AUR
    4/10/2025$6.00Sell → Neutral
    Goldman
    Aurora Innovation Inc.
    $AUR
    3/27/2025$15.00Outperform
    Oppenheimer
    Aurora Innovation Inc.
    $AUR
    3/7/2025$8.00Hold
    TD Cowen
    Aurora Innovation Inc.
    $AUR
    3/3/2025$12.00Overweight
    Morgan Stanley
    bluebird bio Inc.
    $BLUE
    2/24/2025Underweight → Neutral
    Analyst
    bluebird bio Inc.
    $BLUE
    2/24/2025$29.00Overweight
    Analyst
    More analyst ratings

    $AMRN
    $AQMS
    $AUR
    $BLUE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Dow Geoffrey S bought $7,759 worth of shares (9,670 units at $0.80), increasing direct ownership by 19% to 59,618 units (SEC Form 4)

    4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)

    12/16/25 5:41:35 PM ET
    $SXTP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Dow Geoffrey S bought $12,204 worth of shares (12,963 units at $0.94), increasing direct ownership by 35% to 49,948 units (SEC Form 4)

    4 - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Issuer)

    12/12/25 8:39:45 AM ET
    $SXTP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Urmson Christopher bought $1,000,627 worth of shares (258,000 units at $3.88) (SEC Form 4)

    4 - Aurora Innovation, Inc. (0001828108) (Issuer)

    11/26/25 9:09:12 AM ET
    $AUR
    EDP Services
    Technology

    $AMRN
    $AQMS
    $AUR
    $BLUE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 17, 2022 - FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions

    For Immediate Release: August 17, 2022 Today, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions.  “Today’s approval is an important advance in the treatment of beta-thalassemia, particularly in individuals who require ongoing

    8/17/22 2:12:27 PM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMRN
    $AQMS
    $AUR
    $BLUE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alliance Global Partners initiated coverage on Aptera Motors Corp. with a new price target

    Alliance Global Partners initiated coverage of Aptera Motors Corp. with a rating of Buy and set a new price target of $10.00

    3/9/26 9:28:24 AM ET
    $SEV
    Auto Manufacturing
    Industrials

    Needham initiated coverage on Aurora Innovation with a new price target

    Needham initiated coverage of Aurora Innovation with a rating of Buy and set a new price target of $10.00

    4/15/25 7:51:54 AM ET
    $AUR
    EDP Services
    Technology

    Aurora Innovation upgraded by Goldman with a new price target

    Goldman upgraded Aurora Innovation from Sell to Neutral and set a new price target of $6.00

    4/10/25 8:27:26 AM ET
    $AUR
    EDP Services
    Technology

    $AMRN
    $AQMS
    $AUR
    $BLUE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo

    DUBLIN and BRIDGEWATER, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced that additional REDUCE-IT patient subgroup analysis and additional mechanistic data on potential multifactorial biologic activities will be presented at the American College of Cardiology's Annual Scientific Session & Expo, March 28-30, 2026, in New Orleans, LA. Featured Amarin-supported abstracts to be presented by academic collaborators (italicized below) at ACC Scientific Sessions 2026 include: Oral Presentation Efficacy of Icosapent Ethyl Among Patients at Extreme Cardiovascular

    3/16/26 8:15:00 AM ET
    $AMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Brenmiller Energy CEO Avi Brenmiller Issues Letter to Shareholders

    Tel Aviv, Israel--(Newsfile Corp. - March 12, 2026) - Brenmiller Energy Ltd. (NASDAQ:BNRG) ("Brenmiller", "Brenmiller Energy" or the "Company"), a provider of integrated power and heat solutions for industrial and utility customers built around its proprietary thermal energy storage ("TES") technology, today issued a letter from its Chief Executive Officer, Avi Brenmiller. Dear Shareholders,I am writing to you at a pivotal moment for Brenmiller Energy.It has taken us almost fifteen years to reach this point and realize the vision that set us on this journey: replacing fossil fuel-based industrial heat generation with clean, reliable energy. Today, we are beginning to see our vision translate

    3/12/26 8:07:00 AM ET
    $BNRG
    Building Products
    Industrials

    Aptera Motors Announces a Warrant Inducement Transaction for $6.3 Million in Gross Proceeds

    CARLSBAD, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- Aptera Motors Corp. (NASDAQ:SEV) (the "Company" or "Aptera"), a solar mobility company advancing ultra-efficient transportation, today announced the immediate exercise of warrants, previously issued in January 2026, to purchase up to 3,167,500 shares of its Class B Common Stock pursuant to their existing terms for gross cash proceeds of approximately $6.3 million before deducting financial advisor fees and other transaction expenses. In consideration for the immediate cash exercise of the existing warrants, the Company has agreed to issue new, unregistered warrants to purchase up to 4,751,250 shares of Class B Common Stock (the "New War

    3/12/26 8:00:00 AM ET
    $SEV
    Auto Manufacturing
    Industrials

    $AMRN
    $AQMS
    $AUR
    $BLUE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wehner David M. was granted 51,248 shares, increasing direct ownership by 67% to 127,472 units (SEC Form 4)

    4 - Aurora Innovation, Inc. (0001828108) (Issuer)

    3/13/26 4:27:19 PM ET
    $AUR
    EDP Services
    Technology

    New insider Wehner David M. claimed ownership of 397,125 shares (SEC Form 3)

    3 - Aurora Innovation, Inc. (0001828108) (Issuer)

    3/6/26 4:54:51 PM ET
    $AUR
    EDP Services
    Technology

    Chief Executive Officer Cotton Stephen covered exercise/tax liability with 3,307 shares, decreasing direct ownership by 1% to 222,025 units (SEC Form 4)

    4 - Aqua Metals, Inc. (0001621832) (Issuer)

    2/26/26 7:54:41 PM ET
    $AQMS
    Metal Fabrications
    Industrials

    $AMRN
    $AQMS
    $AUR
    $BLUE
    SEC Filings

    View All

    Peraso Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Peraso Inc. (0000890394) (Filer)

    3/16/26 4:07:22 PM ET
    $PRSO
    Semiconductors
    Technology

    SEC Form F-3 filed by Brenmiller Energy Ltd

    F-3 - Brenmiller Energy Ltd. (0001901215) (Filer)

    3/16/26 4:01:32 PM ET
    $BNRG
    Building Products
    Industrials

    SEC Form 6-K filed by Brenmiller Energy Ltd

    6-K - Brenmiller Energy Ltd. (0001901215) (Filer)

    3/16/26 9:36:45 AM ET
    $BNRG
    Building Products
    Industrials

    $AMRN
    $AQMS
    $AUR
    $BLUE
    Leadership Updates

    Live Leadership Updates

    View All

    Aptera Motors Appoints Automotive Industry Veteran Tony Kirton as Chairman of the Board of Directors

    CARLSBAD, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aptera Motors Corp. (NASDAQ:SEV), a solar mobility company advancing ultra-efficient transportation, today announced that Tony Kirton has been appointed Chairman of the Board of Directors. Kirton brings more than four decades of global automotive leadership experience, having held senior executive and board roles across leading automotive brands including Volkswagen, Audi, and BMW. His appointment follows his service as an independent board director and supports Aptera's focus on disciplined governance and long-term value creation as the company prepares for production. "Over my career, I've seen many technologies promise transformation

    1/8/26 4:49:26 PM ET
    $SEV
    Auto Manufacturing
    Industrials

    Data I/O Announces Strengthening of Board of Directors

    Edward Smith Appointed Chair of the Board; Steven Waszak Appointed as Independent Director Data I/O Corporation (NASDAQ:DAIO), the leading global provider of data programming and security provisioning solutions for flash, flash-memory based intelligent devices and microcontrollers, announced changes to its Board of Directors intended to strengthen its leadership as the Company focuses on market expansion. Edward Smith, who has served on the Data I/O Board of Directors since 2022, has been appointed Chair of the Board. Steven Waszak has joined the Board of Directors of Data I/O effective December 3, 2025. Sally Washlow will remain on the Board and assumes the position of independent directo

    12/4/25 8:00:00 AM ET
    $AQMS
    $CIEN
    $DAIO
    Metal Fabrications
    Industrials
    Telecommunications Equipment
    Utilities

    FOXO TECHNOLOGIES INC.'S BIG SOUTH FORK MEDICAL CENTER COMPLETES PERFORMANCE NETWORK AGREEMENT WITH COVENANT HEALTH TO PROVIDE SWING BED SERVICES

    WEST PALM BEACH, FLORIDA, Aug. 01, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that its critical access designated rural hospital, Big South Fork Medical Center located in Oneida, Tennessee, has completed a Performance Network Agreement with Covenant Health to join their performance network as a provider of swing bed services. Covenant Health is a large, muti-facility hospital network serving greater Knoxville and East Tennessee. Patients who no longer meet acute care admission criteria are frequently in need of post-acute care to enhance their recovery. Big South Fork Medical Center is well positioned to provide swing bed services

    8/1/25 7:52:00 AM ET
    $FOXO
    Life Insurance
    Finance

    $AMRN
    $AQMS
    $AUR
    $BLUE
    Financials

    Live finance-specific insights

    View All

    Amarin Reports Fourth Quarter and Full Year 2025 Financial Results

    Strategic Initiatives and Refined Business Model Produced Financial and Operating Efficiencies Established Long-Term License and Supply Agreement to Commercialize VAZKEPA® Across Europe and Sustained U.S. Market Leadership for VASCEPA® Franchise Total of 45 Publications (Abstracts, Posters, Manuscripts) Furthering the Expansion of the VASCEPA® /VAZKEPA® (icosapent ethyl) Body of Knowledge Supported in 2025 DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular disease worldwide, today announced financial results for the fourth quarter and full year ended December 31, 20

    2/25/26 7:00:00 AM ET
    $AMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aurora Triples Driverless Network to 10 Routes and Prepares to Expand Across U.S. Sun Belt

    Company announces fourth quarter and full year 2025 results – Expects to achieve positive free cash flow in 2028 with current liquidity With latest software release, Aurora Driver is now capable of: Routes Exceeding Hours of Service: 1,000 mile driverless lane between Phoenix and Fort Worth extends well beyond current hours of service limitations Direct-to-Customer Lanes: Automated mapping supports new customer endpoints at scale More Uptime: Driverless operations in adverse weather increases utilization Aurora Innovation, Inc. (NASDAQ:AUR) announced it is tripling its driverless network with the launch of its latest software release, which also provides the Aurora Driver with

    2/11/26 4:15:00 PM ET
    $AUR
    EDP Services
    Technology

    Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026

    DUBLIN and BRIDGEWATER, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular care, today announced that it will report fourth quarter and full year 2025 financial results and conduct a conference call on Wednesday, February 25, 2026. The Company will issue a press release detailing its fourth quarter and full year 2025 financial results in the pre-market hours, followed by a conference call with senior management at 8:00 a.m. ET. Information on how to participate is as follows. Access to the live call:Via telephone: Dial in within the United States: 888-506-0062International dial in: 973-528-0011Acces

    2/11/26 8:00:00 AM ET
    $AMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMRN
    $AQMS
    $AUR
    $BLUE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by DSS Inc.

    SC 13D/A - DSS, INC. (0000771999) (Subject)

    12/12/24 9:56:52 PM ET
    $DSS
    Containers/Packaging
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Brenmiller Energy Ltd

    SC 13D/A - Brenmiller Energy Ltd. (0001901215) (Subject)

    12/5/24 11:18:20 AM ET
    $BNRG
    Building Products
    Industrials

    Amendment: SEC Form SC 13G/A filed by ZyVersa Therapeutics Inc.

    SC 13G/A - ZyVersa Therapeutics, Inc. (0001859007) (Subject)

    11/14/24 6:01:27 PM ET
    $ZVSA
    Biotechnology: Pharmaceutical Preparations
    Health Care